About Hexagon Bio
Hexagon Bio is a data-driven biotech company developing targeted small molecule therapeutics.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Undisclosed
Team Size
51-100
Tracked Since
Oct 23, 2026
Web & Domain Identity
Official Website
hexagonbio.com
Domain Registered Date
Oct 27, 2016
Social & Network Presence
X / Twitter Profile
@MHillenmeyer
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $62,000,000 · Series-B
manilatimes.net
- Capital Raise
Raised $47,000,000 · Series-A
Backed by The Column Group, 8VC
- Capital Raise
Seed announced
Backed by 8VC, bpd partners
- Milestone
Website domain registered
hexagonbio.com
Investors & Backers
8VC
bpd partners
genengnews.com
LeFrak
The Column Group
Two Sigma Ventures
Funding History
Series-B equity
· Oct 23, 2026
$62,000,000 manilatimes.net
Series-A equity
· Sep 15, 2020
Round backers: The Column Group, 8VC, LeFrak, Two Sigma Ventures
$47,000,000 goo.gl
Seed equity
· Oct 31, 2017
Round backers: 8VC, bpd partners, genengnews.com
Undisclosed
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026
PAM2L Biotechnologies
pam2l.com
Series-A Shenzhen, China · Oct 2026